Acitretin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00459 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acne (disease) | KG + DL |
| 2 | pediatric systemic lupus erythematosus | KG + DL |
| 3 | fetal erythroblastosis | KG + DL |
| 4 | familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome | KG + DL |
| 5 | complement component 4a deficiency | KG + DL |
| 6 | subacute bacterial endocarditis | KG + DL |
| 7 | familial acanthosis nigricans | KG + DL |
| 8 | prolapse of lacrimal gland | KG + DL |
| 9 | urticaria, familial localized heat | KG + DL |
| 10 | Sjogren syndrome | KG + DL |
| 11 | familial pityriasis rubra pilaris | KG + DL |
| 12 | amenorrhea (disease) | KG + DL |
| 13 | deaf blind hypopigmentation syndrome, Yemenite type | KG + DL |
| 14 | alkaptonuria | KG + DL |
| 15 | syndromic oculocutaneous albinism | KG + DL |
| 16 | inherited cutis laxa | KG + DL |
| 17 | dyschromatosis universalis hereditaria | KG + DL |
| 18 | deafness, congenital, with total albinism | KG + DL |
| 19 | poikiloderma with neutropenia | KG + DL |
| 20 | Tietz syndrome | KG + DL |
| 21 | erythrokeratodermia-cardiomyopathy syndrome | KG + DL |
| 22 | X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome | KG + DL |
| 23 | Buschke-Ollendorff syndrome | KG + DL |
| 24 | anhidrosis, familial generalized, with abnormal or absent sweat glands | KG + DL |
| 25 | aplasia cutis-myopia syndrome | KG + DL |
| 26 | van den Bosch syndrome | KG + DL |
| 27 | brain aneurysm | KG + DL |
| 28 | pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa | KG + DL |
| 29 | keratosis follicularis-dwarfism-cerebral atrophy syndrome | KG + DL |
| 30 | heparin cofactor 2 deficiency | KG + DL |
| 31 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 32 | familial primary localized cutaneous amyloidosis | KG + DL |
| 33 | lacrimal gland neoplasm | KG + DL |
| 34 | antithrombin deficiency type 2 | KG + DL |
| 35 | prolidase deficiency | KG + DL |
| 36 | goiter, multinodular | KG + DL |
| 37 | goiter, multinodular 1, with or without Sertoli-Leydig cell tumors | KG + DL |
| 38 | isolated congenital adermatoglyphia | KG + DL |
| 39 | zinc, elevated plasma | KG + DL |
| 40 | thrombophilia | KG + DL |
| 41 | granulomatous disease, chronic, autosomal recessive | KG + DL |
| 42 | multiple endocrine neoplasia | KG + DL |
| 43 | double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy | KG + DL |
| 44 | optic papillitis | KG + DL |
| 45 | inherited skin tumor | KG + DL |
| 46 | Beare-Stevenson cutis gyrata syndrome | KG + DL |
| 47 | microcephaly microphthalmos blindness | KG + DL |
| 48 | microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome | KG + DL |
| 49 | von Hippel anomaly | KG + DL |
| 50 | ankyloblepharon filiforme adnatum-cleft palate syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.